RDHE2 Antibodies

Santa Cruz Biotechnology features a diverse variety of RDHE2 monoclonal antibodies for advanced research in biochemistry and molecular biology. RDHE2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RDHE2, or retinol dehydrogenase 2, plays a crucial role in the metabolism of retinoids, which are essential for vision, cellular differentiation, and embryonic development. By catalyzing the conversion of retinol to retinal, RDHE2 is integral to the visual cycle and overall retinoid homeostasis. Understanding RDHE2 function is vital for elucidating its implications in various physiological processes and potential pathologies. Researchers worldwide rely on RDHE2 monoclonal antibodies to advance their understanding of retinoid metabolism and its impact on cellular processes. RDHE2 monoclonal antibodies enable detailed investigation of protein expression patterns across different tissues and experimental conditions. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to scientific knowledge in vision and developmental biology.